Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsStapleton, Nigel M
Andersen, Jan Terje
Stemerding, Annette M
Bjarnarson, Stefania P
Verheul, Ruurd C
de Haas, Masja
van der Schoot, C Ellen
MetadataShow full item record
CitationNat. Commun. 2011, 2:599
AbstractHuman IgG3 displays the strongest effector functions of all IgG subclasses but has a short half-life for unresolved reasons. Here we show that IgG3 binds to IgG-salvage receptor (FcRn), but that FcRn-mediated transport and rescue of IgG3 is inhibited in the presence of IgG1 due to intracellular competition between IgG1 and IgG3. We reveal that this occurs because of a single amino acid difference at position 435, where IgG3 has an arginine instead of the histidine found in all other IgG subclasses. While the presence of R435 in IgG increases binding to FcRn at neutral pH, it decreases binding at acidic pH, affecting the rescue efficiency-but only in the presence of H435-IgG. Importantly, we show that in humans the half-life of the H435-containing IgG3 allotype is comparable to IgG1. H435-IgG3 also gave enhanced protection against a pneumococcal challenge in mice, demonstrating H435-IgG3 to be a candidate for monoclonal antibody therapies.
DescriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links field.
RightsArchived with thanks to Nature communications
- Associations between an IgG3 polymorphism in the binding domain for FcRn, transplacental transfer of malaria-specific IgG3, and protection against Plasmodium falciparum malaria during infancy: A birth cohort study in Benin.
- Authors: Dechavanne C, Dechavanne S, Sadissou I, Lokossou AG, Alvarado F, Dambrun M, Moutairou K, Courtin D, Nuel G, Garcia A, Migot-Nabias F, King CL
- Issue date: 2017 Oct
- H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody-mediated diseases of the newborn.
- Authors: Einarsdottir H, Ji Y, Visser R, Mo C, Luo G, Scherjon S, van der Schoot CE, Vidarsson G
- Issue date: 2014 Mar
- Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
- Authors: Suzuki T, Ishii-Watabe A, Tada M, Kobayashi T, Kanayasu-Toyoda T, Kawanishi T, Yamaguchi T
- Issue date: 2010 Feb 15
- Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
- Authors: Gurbaxani B, Dostalek M, Gardner I
- Issue date: 2013 Dec
- Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering.
- Authors: Wang Y, Tian Z, Thirumalai D, Zhang X
- Issue date: 2014 May